Merck Emend — Class II drug recall D-0241-2026
Ongoing recall by Merck Sharp & Dohme LLC, reported 2025-12-31, distributed nationwide. Presence of particulate matter: potential presence of metal particulates in the product.
| Recall number | D-0241-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Merck Sharp & Dohme LLC, Wilson, NC, United States |
| Recall initiated | 2025-12-12 |
| Classified | 2025-12-23 |
| Reported by FDA | 2025-12-31 |
| Distributed | Nationwide (US) |
| Quantity | 3 |
| Reason classes | specification failure |
| NDC | 00006-0461, 00006-0461-01, 00006-0461-02, 00006-0461-06, 00006-0461-12, 00006-0462, 00006-0462-01, 00006-0462-06, 00006-0464, 00006-0464-01, 00006-0464-05, 00006-0464-10, 00006-3066, 00006-3066-01, 00006-3066-03, 00006-3862, 00006-3862-03, 00006-3862-13 |
| Lot numbers | Z014503 |
| Expiration dates | 2027-11-15 |
Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Reason for recall
Presence of particulate matter: potential presence of metal particulates in the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0241-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.